Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients

NCT05155527 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Ivermectin Tablets
OTHER: Placebo

Sponsor

Mahidol University

Collaborators

[object Object]